Efficacy of BRAF Inhibitors in Asian Metastatic Melanoma Patients: Potential Implications of Genomic Sequencing in BRAF-Mutated Melanoma()()

BACKGROUND: The BRAF inhibitors vemurafenib and dabrafenib are currently the standard treatment for metastatic melanoma with BRAF V600 mutations. However, given the rarity of noncutaneous melanoma, including acral and mucosal subtypes, the efficacy of BRAF inhibitors for this subset of patients has...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Transl Oncol
Päätekijät: Kim, Hee Kyung, Lee, Sunyoung, Kim, Kyung, Heo, Mi Hwa, Lee, Hansang, Cho, Jinhyun, Kim, Nayoung K.D., Park, Woongyang, Lee, Su Jin, Kim, Jung Han, Jang, Kee-Taek, Choi, Sang-Hee, Lee, Jeeyun
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Neoplasia Press 2016
Aiheet:
Original article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5122709/
https://ncbi.nlm.nih.gov/pubmed/27883956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2016.09.004
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia